Table 2 . The experimental condition and phenotype of AGRKO under glucocorticoid administration.
| Author | Background | Treatment | Fat mass | Glucose tolerance |
|---|---|---|---|---|
| Bose et al. [24] | C57BL/6 | 10mg/kg dexamethasone for 2 weeks | Increase | No change |
| Shen et al. [26] | N.D. | 3mg/kg dexamethasone every other day for 2 months | No change | Improve |
| Dalle et al. [27] | C57BL/6J (CreERT2) | 100ug/mL corticosterone for 4 weeks | Increase | Improve |
| Hayashi et al. [21] | C57BL/6 | 50ug/mL corticosterone for 2 weeks | Increase | Improve |
N.D.; not described.